Re: Generic Drug Study - Ftc File No. V000014

Book Id: WPLBN0000203519
Format Type: PDF eBook:
File Size: 0.2 MB
Reproduction Date:

Title:	Re: Generic Drug Study - Ftc File No. V000014
Author:
Volume:
Language:	English
Subject:	Trade, Import and export controls, Federal Trade Commission (U.S.)
Collections:	Economics Publications Collection, Federal Trade Commission
Historic Publication Date:
Publisher:	Government Printing Office


Citation APA MLA Chicago Re: Generic Drug Study - Ftc File No. V000014. (n.d.). Re: Generic Drug Study - Ftc File No. V000014. Retrieved from https://self.gutenberg.org/

Description
Government Reference Publication

Excerpt
Dear Sir or Madam: Our organizations, which represent patients and consumers who depend on prescription drugs as an essential part of their health care, commend the Federal Trade Commission for proposing to investigate the anti-competitive practices of pharmacevtical manufacturers. We urge the FTC to investigate a broad range of anti-competitive practices that brand name manufacturers have used to prevent or delay generic alternatives from reaching the market. This investigation has come at a crucial time. Brand name drug companies charge more for prescription drugs in this country than in any other industrialized nation. Drug prices are increasing at a faster rate than inflation or overall healthcare costs. Approximately 65 million Americans have no prescription drug coverage, including one-third of the elderly. Millions more Americans have inadequate drug coverage...